CAPITAL GROUP INVESTMENT MANAGEMENT PTE. LTD.
Position in LLY — ELI LILLY & Co
CIK 1939970
Raffles Quay, U0
Position in LLY
as of Jun 30, 2026
· filed Aug 12, 2026
Position Value
$18,900,619
+$4,688,333 QoQ
Shares Held
15,758
+2.0% QoQ
Ownership
0.002%
of shares outstanding
% of Portfolio
2.88%
of 13F equity value
Holder Rank
#909
of 4,605 holders
Holding Since
Dec 2022
15 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in LLY Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026CAPITAL GROUP INVESTMENT MANAGEMENT PTE. LTD. holds $46,759,706 across 7 Drug Manufacturers - General names. LLY ranks #2 (40.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | AZN |
Astrazeneca PLC
|
106,664 | $20,225,627 | |
| 2 | LLY |
ELI LILLY & Co
This page
|
15,758 | $18,900,619 | |
| 3 | ABBV |
AbbVie Inc.
|
9,584 | $2,411,717 | |
| 4 | PFE |
Pfizer Inc
|
94,728 | $2,281,050 | |
| 5 | AMGN |
Amgen Inc
|
4,068 | $1,473,104 | |
| 6 | BMY |
Bristol Myers Squibb Co
|
15,400 | $887,348 | |
| 7 | GRFS |
Grifols SA
|
81,955 | $580,241 |
All Filings in LLY
Export CSV
15 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $18,900,619 | 15,758 | Shares | Defined | 2026-08-12 | |
| 2026-03-31 | $14,212,286 | 15,452 | Shares | Defined | 2026-05-13 | |
| 2025-12-31 | $17,356,083 | 16,150 | Shares | Defined | 2026-02-11 | |
| 2025-09-30 | $11,491,543 | 15,061 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $12,145,077 | 15,580 | Shares | Defined | 2025-08-13 | |
| 2025-03-31 | $12,918,884 | 15,642 | Shares | Defined | 2025-05-12 | |
| 2024-12-31 | $11,454,936 | 14,838 | Shares | Defined | 2025-02-13 | |
| 2024-09-30 | $12,774,368 | 14,419 | Shares | Defined | 2024-11-13 | |
| 2024-06-30 | $13,243,898 | 14,628 | Shares | Defined | 2024-08-13 | |
| 2024-03-31 | $11,999,255 | 15,424 | Shares | Defined | 2024-05-14 | |
| 2023-12-31 | $12,585,242 | 21,590 | Shares | Defined | 2024-02-13 | |
| 2023-09-30 | $11,790,540 | 21,951 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $10,317,560 | 22,000 | Shares | Defined | 2023-08-11 | |
| 2023-03-31 | $7,848,864 | 22,855 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $9,953,043 | 27,206 | Shares | Defined | 2023-02-14 | |
| No filing history on record for this holder in this stock. | ||||||